Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

0.64USD
7:16pm BST
Change (% chg)

$-0.02 (-2.58%)
Prev Close
$0.66
Open
$0.66
Day's High
$0.66
Day's Low
$0.63
Volume
200,435
Avg. Vol
208,677
52-wk High
$2.44
52-wk Low
$0.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.198
Mar '18 0.00 -0.288
FY 2017 Dec '17 0.25 -0.237
Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.97
Earnings (per share)
Quarter Ending Dec-18 3 -0.14 -0.09 -0.23 -0.29
Quarter Ending Mar-19 1 -0.09 -0.09 -0.09 -0.39
Year Ending Dec-18 3 -0.68 -0.54 -0.95 -1.10
Year Ending Dec-19 3 -0.56 -0.34 -0.95 -1.37
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.92 33.73
P/E High - Last 5 Yrs. -- 289.06 45.21
P/E Low - Last 5 Yrs. -- 90.26 23.82
Beta -- 0.94 0.88
Price to Sales (TTM) -- 123.71 5.82
Price to Book (MRQ) 2.60 15.32 4.90
Price to Tangible Book (MRQ) 2.60 14.53 6.53
Price to Cash Flow (TTM) -- 70.52 22.98
% Owned Institutions 37.97 14.06 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.38
Payout Ratio(TTM) -- 16.85 43.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.79 8.03
Sales (TTM) vs TTM 1 Yr. Ago -- 103.76 5.76
Sales - 5 Yr. Growth Rate -- 30.82 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.92 24.48 22.57
EPS (TTM) vs TTM 1 Yr. Ago 27.59 -- --
EPS - 5 Yr. Growth Rate -- 37.84 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.59 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 3.72 5.32 3.05
LT Debt to Equity (MRQ) 3.86 34.92 12.63
Total Debt to Equity (MRQ) 19.07 36.74 16.96
Interest Coverage (TTM) -41.02 -97.26 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.17 54.92
Gross Margin - 5 Yr. Avg. -- 49.26 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.48 11.06
Operating Margin (TTM) -- -770.44 4.32
Operating Margin - 5 Yr. Avg. -- -595.77 6.41
Pre-Tax Margin (TTM) -- -732.46 5.37
Pre-Tax Margin - 5 Yr. Avg. -- -601.16 6.85
Net Profit Margin (TTM) -- -733.39 1.64
Net Profit Margin - 5 Yr. Avg. -- -604.13 3.10
Effective Tax Rate (TTM) -- 23.66 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.81 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,811,841 812,819,528
Net Income/Employee (TTM) -843,342 1,720,762 95,602,483
Receivable Turnover (TTM) -- 19.83 5.78
Inventory Turnover (TTM) -- 2.38 3.60
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.03 -1.05 10.93
Return on Assets - 5 Yr. Avg. -- 3.23 12.05
Return on Investment (TTM) -107.14 0.63 14.31
Return on Investment - 5 Yr. Avg. -- 2.31 15.65
Return on Equity (TTM) -117.90 1.68 16.04
Return on Equity - 5 Yr. Avg. -- 3.16 16.92
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -4.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.25%
# of Holders: 37
Total Shares Held: 37,118,876
3 Mo. Net Change: 9,942
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.